|
BPTF expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.394200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.200600E-01 |
| Normal-vs-Stage2 |
3.135000E-01 |
| Normal-vs-Stage3 |
2.657100E-03 |
| Normal-vs-Stage4 |
7.5808000000066E-05 |
| Stage1-vs-Stage2 |
2.928800E-01 |
| Stage1-vs-Stage3 |
3.417700E-04 |
| Stage1-vs-Stage4 |
6.16669999953245E-07 |
| Stage2-vs-Stage3 |
1.250610E-01 |
| Stage2-vs-Stage4 |
1.991710E-02 |
| Stage3-vs-Stage4 |
2.039600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.408000E-02 |
| Normal-vs-AfricanAmerican |
5.627800E-01 |
| Normal-vs-Asian |
1.024820E-01 |
| Caucasian-vs-AfricanAmerican |
3.458400E-01 |
| Caucasian-vs-Asian |
2.206100E-02 |
| AfricanAmerican-vs-Asian |
1.217990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.297600E-02 |
| Normal-vs-Female |
4.971200E-01 |
| Male-vs-Female |
4.523700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.122800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.215000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.940400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.162370E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.413800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.351200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.023200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.724100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.752500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.700210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.522000E-03 |
| Normal-vs-Grade 2 |
9.701000E-01 |
| Normal-vs-Grade 3 |
1.964210E-03 |
| Normal-vs-Grade 4 |
2.825500E-04 |
| Grade 1-vs-Grade 2 |
1.581980E-02 |
| Grade 1-vs-Grade 3 |
4.09700000003621E-06 |
| Grade 1-vs-Grade 4 |
1.81880000005297E-06 |
| Grade 2-vs-Grade 3 |
4.4275000000038E-05 |
| Grade 2-vs-Grade 4 |
1.66231999999544E-05 |
| Grade 3-vs-Grade 4 |
1.456760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.611600E-01 |
| Normal-vs-ccB subtype |
4.850400E-02 |
| ccA subtype-vs-ccB subtype |
4.120100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.061400E-01 |
| Normal-vs-N1 |
2.085400E-01 |
| N0-vs-N1 |
6.740800E-01 |
|
|
